Johnson & Johnson said late Thursday that its single-shot COVID-19 vaccine generated strong, persistent activity against the Delta variant, and other highly prevalent variants.
Data showed that the durability of the immune response lasted through at least eight months, the company said.
J&J says its single-shot COVID vaccine shows strong activity against Delta
By REUTERS
03/07/2025 03:34 PM
By REUTERS
03/07/2025 03:07 PM
By REUTERS
03/07/2025 02:51 PM
By REUTERS
03/07/2025 01:25 PM
By REUTERS
03/07/2025 12:18 PM
By REUTERS
03/07/2025 12:09 PM
By REUTERS
03/07/2025 11:19 AM
By REUTERS
03/07/2025 11:04 AM
By REUTERS
03/07/2025 10:06 AM
By REUTERS
03/07/2025 07:06 AM
By REUTERS
03/07/2025 04:00 AM